StonvexLoading…
StonvexStonvexStonvexCore line items from BIIB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.47B | $2.48B | $9.89B | $7.61B | $5.08B |
Operating Income | Not available | $377.70M | $1.56B | $1.61B | $1.06B |
Net Income | Not available | $319.50M | $1.29B | $1.34B | $875.30M |
EPS (Diluted) | $3.24 | $2.15 | $8.79 | $9.14 | $5.97 |
Total Assets | Not available | $29.48B | $29.44B | $29.21B | $28.33B |
Total Liabilities | Not available | $10.83B | $11.18B | $11.00B | $10.70B |
Cash & Equivalents | Not available | $3.38B | $3.01B | $3.86B | $2.76B |
Free Cash Flow OCF − CapEx | Not available | $594.30M | $2.05B | $1.58B | $356.50M |
Shares Outstanding | Not available | 148.40M | 146.80M | 146.80M | 146.70M |